Related content

Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase

By Georgitsi Marianthi   Viennas Emmanouil   Gkantouna Vassiliki   Christodoulopoulou Elena   Zagoriti Zoi   Tafrali Christina   Ntellos Fotios   Giannakopoulou Olga   Boulakou Athanassia   Vlahopoulou Panagiota   Kyriacou Eva   Tsaknakis John   Tsakalidis Athanassios   Poulas Konstantinos   Tzimas Giannis   Patrinos George P  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 49-58

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease

By Blum Shany   Milman Uzi   Shapira Chen   Levy Andrew P  

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 989-991

Future Medicine

Access to resources Recommend Favorite

Application of Pharmacogenomic Approaches in the Study of Drug Response in Complex Diseases

By  

Current Pharmacogenomics, Vol. 3, Iss. 3, 2005-09 ,pp. : 177-190

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of a pharmacogenomic marker panel in a polypharmacy population identified from electronic medical records

By Oetjens Matthew T   Denny Joshua C   Ritchie Marylyn D   Gillani Niloufar B   Richardson Danielle M   Restrepo Nicole A   Pulley Jill M   Dilks Holli H   Basford Melissa A   Bowton Erica   Masys Dan R   Wilke Russell A   Roden Dan M   Crawford Dana C  

Pharmacogenomics, Vol. 14, Iss. 7, 2013-05 ,pp. : 735-744

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomic-Guided Rational Therapeutic Drug Monitoring: Conceptual Framework and Application Platforms for Atypical Antipsychotics

By  

Current Medicinal Chemistry, Vol. 11, Iss. 3, 2004-02 ,pp. : 297-312

Bentham Science Publishers

Access to resources Recommend Favorite